Compare BioNTech SE - ADR (BNTX) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Cassava Sciences Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: BioNTech SE - ADR is far larger — about 488.2× Cassava Sciences Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | FLNA | |
|---|---|---|
Market Cap | $23.31B | $47.75M |
Sector | Health | Health |
52-Week High | $119.34 | $4.64 |
52-Week Low | $83.89 | $0.87 |
Enterprise Value | $6.60B | -$34.93M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
